Skip to main content
. 2021 Feb 18;29(6):2008–2018. doi: 10.1016/j.ymthe.2021.02.019

Figure 6.

Figure 6

Gene editing-based correction in CB-CD34+ cells and BM-MSCs

(A) CD34+ HDR-based gene-editing frequencies in CD34+ cells from three healthy donors (HD 1–3), showing HDR percentages in all samples. (B) MSC HDR-based gene-editing frequencies in three healthy donors (HD 1–3). Treated P1 keratinocytes (C+ HK P1) were included as reference. MOIs of 5,000, 10,000, and 30,000 were used.